MET exon 14 skipping

What Are Patients and Caregivers Talking About? Lung Cancer Biomarkers
topic1

What Are Patients and Caregivers Talking About? Lung Cancer Biomarkers

What Are Patients and Caregivers Talking About? Lung Cancer Biomarkers By Kathleen Hoffman, PhD, MSPH Since the FDA approved the first targeted treatment for NSCLC in 2003, treatment decisions for NSCLC are increasingly made based on individual genomics.1,2 There are now 20 distinct biomarkers that serve as identification points differentiating cancer cells [...]

Sep 2021By Kathleen Hoffman, PhD, MSPH|topic1|0 Comments

Good News about Lung Cancer? Thanks to Bench Science and Pharma
topic1

Good News about Lung Cancer? Thanks to Bench Science and Pharma

Good News about Lung Cancer? Thanks to Bench Science and Pharma By Kathleen Hoffman, PhD, MSPH Targeted therapies, monoclonal antibodies, and immune checkpoint inhibitors are the good news - making a significant difference in lung cancer mortality, a new study states. Published in The New England Journal of Medicine, the report said, [...]

Nov 2020By Kathleen Hoffman, PhD, MSPH|topic1|0 Comments